Joe Ingles (Utah Jazz) with a deep 3 vs the Sacramento Kings, 04/10/2021
Joe Ingles (Utah Jazz) with a deep 3 vs the Sacramento Kings, 04/10/2021
Paul DeJong hit a two-run homer, Paul Goldschmidt added a solo shot off Marcus Stroman and the St. Louis Cardinals beat the New York Mets 4-1 in a doubleheader opener on Wednesday that extended their winning streak to six. Kwang Hyun Kim pitched four innings, combining with Ryan Hemsley (3-0), Giovanny Gallegos and Alex Reyes (ninth save in nine chances) on a two-hitter. While the Mets received uplifting news earlier in the day when manager Luis Rojas said ace Jacob deGrom could return to the rotation on Sunday, skidding New York did little at the plate in its first game after hitting coach Chili Davis was fired and replaced by Hugh Quattlebaum.
Out of all T-cell Leukemia pipeline therapies, HBI-8000 is set to capture the maximum patient pool owing to its immunomodulatory function.Los Angeles, USA, May 05, 2021 (GLOBE NEWSWIRE) -- T-cell Leukemia Pipeline: Comprehensive Analysis of 15+ Key Players and 15+ Key Therapies Out of all T-cell Leukemia pipeline therapies, HBI-8000 is set to capture the maximum patient pool owing to its immunomodulatory function. DelveInsight’s ‘T-cell Leukemia Pipeline Insights’ report provides a holistic view of the pipeline therapies that are under development in pre-clinical as well as clinical stages of development, and growth prospects across the T-cell Leukemia domain. Some of the key highlights of the T-cell Leukemia Pipeline report: T-cell Leukemia Pipeline report offers a comprehensive analysis of 15+ key players and 15+ key therapies.Out of all the emerging therapies, HBI-8000 is expected to capture the maximum patient pool owing to its immunomodulatory function. This oral agent targets class I histone deacetylase causing cell cycle arrest and tumor cell death as the mechanism underlying its single-agent activity against lymphoma.T-cell Leukemia pipeline comprises ASTX 660 (Otsuka Pharmaceutical) is in phase I/II while Valemetostat and Brentuximab vedotin (Seagen/Takeda) is in Phase II stage of development. HUYA Bioscience appears to have an upper edge as its therapy, HBI-8000 which is in the pre-registration phase. In April 2021, Shorla Pharma announced that the U.S. Food and Drug Administration (FDA) has accepted the filing application of its oncology drug SH-111 which is designed to treat T-cell Leukemia. Got queries? Want to know more? Request for Sample @ T-cell Leukemia Emerging Therapies and Forecast The report lays down a complete coverage of the therapeutics by development stage, product type, and route of administration, molecule type, and MOA type for T-cell Leukemia across the complete product development cycle, including all clinical and non-clinical stages. The T-cell Leukemia pipeline report puts on the table business opportunities, threats, prospective collaborations, strong competitors, growth strategies, and failed as well as discontinued drugs. T-cell Leukemia Pipeline Drugs DrugCompanyClinical PhaseMoARoAValemetostatDaiichi SankyoPhase IIHistone-lysine N-methyltransferase inhibitorsOralBNZ-1BionizPhase IIInterleukin receptor antagonistsIntravenousASTX 660Otsuka PharmaceuticalPhase I/IIInhibitor of apoptosis protein inhibitors; OralBrentuximab vedotinSeagen /TakedaPhase IIApoptosis stimulantsIntravenousHBI-8000HUYA BiosciencePreregistrationRas protein inhibitorsOral Request for Sample to know more @ T-cell Leukemia Pipeline Analysis, Key Companies and Futuristic Trends T-cell Leukemia Therapeutic Assessment The T-cell Leukemia Pipeline report proffers exhaustive insights into active pipeline assets segmented by Stage, Product Type, Route of Administration, Molecule Type, Target, and Indications of various drugs. By Product Type MonoCombination By Stage Discovery Pre-clinicalINDPhase IPhase IIPhase IIIPre-registration By Molecule Type Small Molecule Gene TherapyStem Cell Therapy By Route of Administration IntravenousInhalationOralSubcutaneous By Mechanism of Action Enhancer of zeste homolog 1 and 2 protein inhibitorsHistone-lysine N-methyltransferase inhibitorsInterleukin 15 receptor antagonistsInterleukin 2 receptor antagonistsInterleukin 9 receptor antagonists1 Phosphatidylinositol 3 kinase inhibitors HDAC 1,2,3, and 10 protein inhibitorsMitogen-activated protein kinase inhibitors By Targets Protease Multiple Kinase Interleukin 15 receptorInterleukin 2 receptor Interleukin 9 receptorHistone-lysine N-methyltransferase Get in touch with our Business executive for Rich and Deep Market Assessment and Consulting Solutions Scope of the Report Coverage: GlobalKey Players: Daiichi Sankyo; Bioniz; Otsuka Pharmaceutical; Seagen /Takeda; HUYA Bioscience; iCell Gene Therapeutics; Gracell Biotechnology; Ascentage Pharma Group; Celgene Corporation; Shorla Pharma; AVM Biotechnology; Expression Therapeutics; miRagen Therapeutics, and others.Key T-cell Leukemia Pipeline Therapies: Valemetostat; BNZ-1; ASTX 660; Brentuximab vedotin; HBI-8000; CD4CAR; CD7 UCAR-T cells; APG-115; Romidepsin; SH-111; Cobomarsen; AVM-0703, and others. Reach out @ T-cell Leukemia Pipeline: Novel therapies and emerging technologies Table of Contents 1Introduction2Executive Summary3T-cell Leukemia Overview4T-cell Leukemia Pipeline Therapeutics5T-cell Leukemia Pipeline Therapeutic Assessment6T-cell Leukemia – DelveInsight’s Analytical Perspective7In-depth Commercial T-cell Leukemia Pipeline Assessment8T-cell Leukemia Collaboration Deals9Late Stage T-cell Leukemia Pipeline Products (Phase III and Preregistration)10Mid-Stage T-cell Leukemia Pipeline Products (Phase II)11Pre-clinical and Discovery Stage T-cell Leukemia Pipeline Products12Inactive T-cell Leukemia Pipeline Products13T-cell Leukemia Key Companies14T-cell Leukemia Key Products15T-cell Leukemia Unmet Needs16T-cell Leukemia Market Drivers and Barriers17T-cell Leukemia Future Perspectives and Conclusion18T-cell Leukemia Pipeline Analyst Views20Appendix Visit to know more of what’s covered @ T-cell Leukemia Emerging Therapies Browse through Related Reports CAR T-Cell Therapy for Acute Lymphoblastic LeukemiaDelveInsight’s “CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL)- Market Insights and Market Forecast- 2030” report. CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Pipeline DelveInsight’s, “CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Acute Lymphoblastic Leukemia pipeline landscape. Adult T Cell Leukemia Lymphoma MarketDelveInsight's "Adult T-Cell Leukemia-Lymphoma - Market Insights, Epidemiology, and Market Forecast-2030" report. Acute Myeloid Leukemia MarketDelveInsight's "Acute Myeloid Leukemia (AML) Market Insights, Epidemiology, and Market Forecast-2030" report. B-Cell Chronic Lymphocytic Leukemia MarketDelveInsight's "B-Cell Chronic Lymphocytic Leukemia - Market Insights, Epidemiology, and Market Forecast-2030" report. Hairy Cell Leukemia Market Insight Epidemiology and Market ForecastDelveInsight's 'Hairy Cell Leukemia (HCL)- Market Insights, Epidemiology and Market Forecast-2028' report. Bowens Disease MarketDelveInsight's "Bowen's Disease - Market Insights, Epidemiology, and Market Forecast-2030" report. Buergers Disease MarketDelveInsight's "Buerger’s Disease - Market Insights, Epidemiology, and Market Forecast-2030" report. Brucellosis MarketDelveInsight's "Brucellosis - Market Insights, Epidemiology, and Market Forecast-2030" report. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. For more insights, visit Pharma, Healthcare, and Biotech News CONTACT: Shruti Thakur email@example.com +1(919)321-6187 www.delveinsight.com
Ikänik Farms, Inc. (CSE: IKNK.U) (FSE: DFMA) (the "Company" or "Ikänik Farms") has been advised by the Ontario Securities Commission that it will be issuing a failure-to-file cease trade order ("CTO") against the Company.
A cross-party group of more than 60 MPs and peers has asked the government urgently to reconsider plans to cut UK overseas aid for lifesaving water projects to the poorest nations. In a letter to foreign office minister Wendy Morton, they said such a move is "particularly disappointing" in the middle of a pandemic where handwashing is a frontline of defence against coronavirus. The 29 MPs and 37 peers wrote that Britain has a proud record of "standing up for the most vulnerable and stepping in to help those in need".
Equinox Gold Corp. (TSX: EQX) (NYSE American: EQX) ("Equinox Gold" or the "Company") is pleased to announce that Equinox Gold shareholders approved all matters voted on at the annual general meeting held earlier today including the election of management's nominees as directors, the appointment of KPMG LLP as the Company's independent auditor, amendments to the Company's Articles, and acceptance of the Company's approach to executive compensation ("Say on Pay"). Each of the matters voted on at the meeting are described in detail in the Company's Management Information Circular dated March 12, 2021, which is available on the Company's website at www.equinoxgold.com. A total of 140,100,255 common shares were represented at the meeting, being 57.74% of the Company's issued and outstanding common shares.
Amaravati (Andhra Pradesh) [India], May 6 (ANI): As part of the partial curfew and Section 144 imposed in Andhra Pradesh, the Srikakulam district police on Wednesday held a COVID-19 awareness rally with 10 vehicles in all major junctions of the town.
‘Rejected and betrayed’: Australians stranded in India speak of heartbreakMore than 9,000 Australians remain trapped in India by the Coalition’s Covid travel ban. Many travelled before the crisis to visit sick and dying relatives, and say they are angry at their treatment. Here are six of their stories (Clockwise from top) Subra Somayajula, Paramjit Khare, Vishal Dhanda, Shruthi Parepalli, Vamshi Parepalli, and Ramana Akula are all Australia citizens who are stranded in India due to the Morrison government’s travel ban. Many say Christmas Island detention centre should be used as a quarantine facility to accept arrivals from India immediately. Composite: Supplied
The governor has said he will sign the bill, which is meant to address a shortage in lethal injection drugs
NEW YORK, May 05, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Churchill Capital Corp IV (NYSE: CCIV) between January 11, 2021 and February 22, 2021, inclusive (the “Class Period”), of the important June 28, 2021 lead plaintiff deadline. SO WHAT: If you purchased Churchill Capital securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Churchill Capital class action, go to http://www.rosenlegal.com/cases-register-2083.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email firstname.lastname@example.org or email@example.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 28, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting a production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Churchill Capital class action, go to http://www.rosenlegal.com/cases-register-2083.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email firstname.lastname@example.org or email@example.com for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 firstname.lastname@example.org email@example.com firstname.lastname@example.org www.rosenlegal.com
WASHINGTON — No. 3 House Republican Liz Cheney was clinging to her post Wednesday as party leaders lined up behind an heir apparent, signalling that fallout over her clashes with former President Donald Trump was becoming too much for her to overcome. Unbowed, she implored her GOP colleagues to pry themselves from a Trump “cult of personality," declaring that the party and even American democracy were at stake. “History is watching,” she said. Trump issued a statement giving his “COMPLETE and TOTAL Endorsement” to Rep. Elise Stefanik of New York to replace Cheney. Stefanik, a 36-year-old Trump loyalist who’s played an increasingly visible role within the GOP, responded quickly, highlighting his backing to colleagues who will decide her political future. “Thank you President Trump for your 100% support for House GOP Conference Chair. We are unified and focused on FIRING PELOSI & WINNING in 2022!” she tweeted. The day's events left the careers of Cheney and Stefanik seemingly racing in opposite directions, as if to contrast the fates awaiting Trump critics and backers in today's GOP. The turmoil also raised questions about whether the price for political survival in the party entails standing by a former president who keeps up his false narrative about a fraudulent 2020 election and whose supporters stormed the Capitol just four months ago in an attempt to disrupt the formal certification of Joe Biden's victory. Cheney showed no signs of backing off in an opinion essay posted Wednesday by The Washington Post. She denounced the “dangerous and anti-democratic Trump cult of personality,” and warned her fellow Republicans against embracing or ignoring his statements “for fundraising and political purposes.” She said House Minority Leader Kevin McCarthy, R-Calif., has “changed his story” after initially saying Trump “bears responsibility” for the Jan. 6 attack on the Capitol. McCarthy, who is tacitly backing the drive to oust her, has since said Trump issued a video to try halting the violence. Cheney, in the Post, agreed with Democrats that a bipartisan investigation should focus solely on the riot and not on disturbances at some of last summer's racial justice protests. In an apparent reference to her own situation, she said she would defend “basic principles” of democracy, “no matter what the short-term political consequences might be.” Dozens of state and local officials and judges from both parties have found no evidence to support Trump's assertions that he was cheated out of an election victory. President Biden told reporters at the White House that the GOP is in the throes of a “significant sort of mini revolution.” He added, “I think Republicans are further away from trying to figure out who they are and what they stand for than I thought they would be at this point.” Cheney, a daughter of Dick Cheney, who was George W. Bush’s vice-president and before that a Wyoming congressman, seemed to have almost unlimited potential until this year. Her career began listing after she was among just 10 House Republicans to back Trump’s impeachment for inciting supporters to attack the Capitol on Jan. 6, when five died. Combined with a morning endorsement from No. 2 House Republican leader Steve Scalise of Louisiana and tacit backing from McCarthy, the momentum behind Stefanik's ascension was beginning to seem unstoppable. Stefanik, who represents a mammoth upstate New York district, began her House career in 2015 as a moderate Republican. She spoke out against Trump's ban on immigration from seven majority-Muslim countries, and joined Democrats in voting against Trump's effort to unilaterally redirect money to building a wall along the Southwest border. She also led an effort to recruit female candidates for her party. Stefanik's rural district, which Barack Obama carried in his successful 2008 and 2012 presidential runs, was subsequently won twice by Trump. She morphed into a stalwart Trump defender and was given a high-profile role during the 2019 House Intelligence Committee impeachment hearings. That was widely seen as a strategic move by the GOP to soften its image by giving a woman a prominent role. Stefanik's status and visibility within the GOP have soared since then, and she's also become a significant fundraiser for the party. Cheney is the highest-ranking woman in the GOP leadership. Replacing her with Stefanik — and not a man — is seen as politically wise as the party tries to bolster its weak appeal among female voters. There are just 31 Republican women in the House, about one-third of Democrats’ total but up from the 13 who served in the last Congress. There were no other visible contenders for Cheney's post, with a secret ballot by House Republicans on her fate possible next week. A vote on a replacement, seemingly Stefanik, could come that day as well. Two Republicans said another GOP woman, Rep. Virginia Foxx of North Carolina, was expected to make the formal motion to remove Cheney. Cheney was making little noticeable effort to cement support by calling colleagues or enlisting others to lobby on her behalf, said two House GOP aides who spoke on condition of anonymity to describe the situation. A third person familiar with Cheney's effort also said she was not lining up votes. Cheney’s opposition to Trump put her out of step with most House Republicans, 138 of whom voted against certifying the Electoral College vote for Biden’s victory. Trump's statement Wednesday underscored his bitter rift with Cheney. He called Cheney “a warmongering fool who has no business in Republican Party Leadership." He praised Stefanik for supporting his America First agenda and added that she "has my COMPLETE and TOTAL Endorsement for GOP Conference Chair. Elise is a tough and smart communicator!" Rep. Steve Scalise, the House GOP whip, is also backing Stefanik, said Scalise spokesperson Lauren Fine. The Louisiana Republican's was the first explicit call from House GOP leadership to oust Cheney from her leadership job. Stefanik is committed to focusing on Republican efforts to gain House control in the 2022 elections “and fighting against Speaker Pelosi and President Biden’s radical socialist agenda,” said the statement from Fine. Scalise's backing was first reported by Punchbowl, a political news organization. McCarthy said Tuesday that rank-and-file Republicans were concerned about Cheney's “ability to carry out her job” because of her public comments about Trump. Republicans say a McCarthy speech backing Cheney at a closed-door House GOP meeting in February was largely credited with her surviving an earlier push by conservatives oust her, in a 145-61 secret ballot. A top House GOP aide has said McCarthy won’t do that this time. Senate Minority Leader Mitch McConnell, R-Ky., kept his distance Wednesday from the House GOP struggle. Asked if he would help Cheney, he told reporters in Georgetown, Kentucky, “100% of my focus in on stopping this new administration.” ___ AP reporters Steve Peoples in New York, Bruce Schreiner in Frankfort, Kentucky, and Lisa Mascaro, Jill Colvin, Alexandra Jaffe and Kevin Freking in Washington contributed to this report. Alan Fram, The Associated Press
The cast members in a theatrical performance being staged virtually this week aren't likely to attack anyone who parks in a handicapped spot, but their fictional characters might. Wheel Voices: Tune In! is a mashup of original scenes, rap, spoken word and songs featuring 14 Lower Mainland artists. It is the latest production by Realwheels Theatre, a company dedicated to telling stories that deepen people's understanding about disabilities. The show premiers online at 7 p.m. Wednesday and includes a parody of the famous Cell Block Tango song from the 1975 musical Chicago in which six female prisoners share via song the details of the murders they committed that put them behind bars. "They had it coming, they only have themselves to blame," the women sing. In Wheel Voices, the song is titled Disability Cell Block Tango and the victims are people who cut in front of wheelchair users to access public transit, people who take up handicapped spots and others who have disrespected people living with disabilities. Amelia Cooper says it's frustrating when people cut in front of wheelchair users to access public transit.(Facebook/RealwheelsTheatre) "We always think about what we would do to those people," said performer Amelia Cooper, during an interview with CBC's The Early Edition guest host Michelle Eliot. As a wheelchair user, she's irked by people who cut in line through the wheelchair gate at transit stations. Another move she finds offensive is when people offer to bring up her situation with God. "I've had multiple people come up to me and try to pray for me," said Cooper. The chorus of Disability Cell Block Tango reveals the characters sought the ultimate revenge on all these offenders: "Compass gate, prayer circle, parking spot ... they had it coming," is the parody's chorus. Cooper said creating these characters and their costumes was a blast. She plays an incarcerated drug dealer who trades narcotics for crafts while in jail. A jail where the cells have wheelchair buttons. "Part of the reason we do it is to bring about awareness so that people know and they can try and help reduce the amount of struggles that people with disabilities have to go through," said Cooper about staging productions with a purpose. Wheel Voices: Tune In! can be watched online at 7 p.m. PT on Wednesday, May 5, with American Sign Language interpretation. A second performance will be presented at the same time on May 14 with audio description. Both performances are followed by a Q&A with cast and crew.
The first period between the Washington Capitals and New York Rangers featured several fights, in an ugly moment for the NHL.
CALGARY, Alberta, May 05, 2021 (GLOBE NEWSWIRE) -- Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Company”) announces that all matters presented for approval at the Annual General and Special Meeting of Shareholders held May 5, 2021 have been fully authorized and approved. The items on the agenda included fixing the number of directors to be elected at seven, electing seven proposed director nominees, appointment of Ernst & Young LLP as auditors, approval of the amendment and reconfirmation of the Company’s shareholder rights plan and approval of the omnibus long term incentive plan. The results of the voting, inclusive of all votes cast and proxies received for each director nominee, which was conducted by ballot, are as follows: NomineeVotes ForVotes WithheldNo.%No.%Ronald Eckhardt100,792,42497.62,494,0542.4Bryan Begley100,368,40197.22,918,0772.8Robert Broen100,117,34396.93,169,1353.1Anne Downey100,459,90297.32,826,5762.7Thomas Ebbern100,270,40197.13,016,0772.9Carlos Fierro100,270,40197.13,016,0772.9John Festival101,045,13997.82,241,3392.2 About Athabasca Oil Corporation Athabasca Oil Corporation is a Canadian energy company with a focused strategy on the development of thermal and light oil assets. Situated in Alberta’s Western Canadian Sedimentary Basin, the Company has amassed a significant land base of extensive, high quality resources. Athabasca’s common shares trade on the TSX under the symbol “ATH”. For more information, visit www.atha.com. For more information, please contact:Matthew TaylorChief Financial Officer1email@example.com
John Means throws a no-hitter in Orioles' 6-0 win
The rocket concept chosen by Nasa to land astronauts on the Moon completes an impressive test flight.
"I wish I could say this didn't hurt, but it does," TJ Osborne wrote in a since-expired Instagram Story post
Health Canada approved the Pfizer-BioNTech vaccine for children 12 and older on Wednesday, prompting Alberta, the Northwest Territories and Manitoba to announce they would offer the shot to kids in that age bracket as part of their efforts to combat COVID-19. The vaccine announcement came after a promising trial out of the United States, which Health Canada's chief medical adviser said shows the shot is both safe and effective for kids in that age group. "It will also support the return to a more normal life for our children, who have had such a hard time over the past year," said Dr. Supriya Sharma. The shot had previously only been approved for those aged 16 and up. The American trial of more than 2,200 youth between the ages of 12 and 15, which used the same size doses and two-dose requirement as the vaccine for adults, recorded no cases of COVID-19 among vaccinated kids. Sharma said about a fifth of all COVID-19 cases in Canada have occurred in kids and teens. Alberta Premier Jason Kenney was the first to announce that starting on Monday, his hard-hit province would make vaccines available to everyone aged 12 and up. Those born in 1991 and earlier can start booking their vaccines on Friday, while those born between 1992 and 2009 can make an appointment starting Monday. The news came the day after high COVID-19 transmission rates forced the province to announce the closure of schools. Kenney said students would move to online learning starting Friday, with the measure set to last for two weeks. Thousands of students in higher grades in Edmonton and Calgary have already been learning from home. Kenney also introduced tighter caps on outdoor gatherings and customer capacity in retail stores. Manitoba announced its own plan to vaccinate youth later Wednesday, saying it aims to have those 12 and up eligible to book a vaccine by May 21. However, the medical lead of the province's vaccine effort said it hasn't yet been determined whether teenagers will be prioritized for immunization over older people. The Northwest Territories says it will offer vaccinations to young people between 12 and 17 starting Thursday. The territory has only been using the Moderna vaccine but it expects just over 1,100 doses of the Pfizer product to arrived from British Columbia on Tuesday. In Ontario, provincial officials said they were working on a plan to immunize children 12 and up. Health Minister Christine Elliott said vaccines could be administered through schools, with both doses given before the next school year, but did not give a precise timeline. Meanwhile, public health officials and politicians alike were working to reassure Canadians about the safety of the Oxford-AstraZeneca vaccine after the National Advisory Committee on Immunization urged those who were not at high risk of COVID-19 infection or complications to wait for another shot. "You know, what I say is that if your life is in danger, and you need to call 911, to get help to save your life, it does not matter if that call is made on an iPhone or a Samsung or even a flip phone," said Sharma, the Health Canada adviser. "It does what it is supposed to do." British Columbia said 12- to -17-year-olds could possibly be vaccinated before the end of June following Health Canada's decision. New Brunswick health officials reported the province's first death of someone who developed a rare blood clot after receiving the Oxford-AstraZeneca vaccine on Wednesday, just hours after Alberta did the same. "It is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine," said Dr. Deena Hinshaw, Alberta's chief medical officer of health. Hospitalizations due to COVID-19 increased by three per cent across Canada in the most recent seven-day period compared with the previous week, the country's top public health doctor said in a statement Wednesday. That includes an average of 1,458 people who were being treated in intensive care units – a five-per-cent increase over the previous week, Dr. Theresa Tam said. Deaths from the virus have levelled off, but the rise in hospitalizations and intensive care admissions could change that, she warned. Also on Wednesday, Quebec reported a lower COVID-19 infection rate than Nova Scotia– a first since the pandemic began more than a year ago. The province logged 104 active cases per 100,000 people, while Nova Scotia had 108. A day earlier, Ontario reported 247 active cases for every 100,000 people, while Alberta had 534. Also on Wednesday, the federal government announced that Canada is sending desperately needed medical supplies to India as the COVID-19 pandemic in that country spirals out of control. Global Affairs Canada said Ottawa is shipping up to 25,000 vials of the antiviral drug remdesivir and as many as 350 ventilators from its emergency stockpile in response to the critical situation. In India, images of packed hospitals and sick people sharing oxygen masks on the street are driving home the scope of the country's latest wave, with COVID-19 deaths reaching a new high of 3,780 in the last 24 hours as daily infections rose by more than 382,000. This report by The Canadian Press was first published May 5, 2021. Nicole Thompson and Paola Loriggio, The Canadian Press
Beatriz Ramon and her younger brother Oscar heard a ferocious bang and saw the lights snap out as they left a grocery store in southeastern Mexico City just before 10:30pm on Monday night, right across the street from the metro line. But when the electricity returned minutes later, Ramon saw white smoke rising from the metro, and two orange wagons plunged into a V-shape between the elevated track that had snapped in two. "I thought I might hear yells of the people inside… but just the opposite, it was silence," Ramon said.
President Joe Biden’s recent address to Congress focused rather heavily on domestic matters, particularly his $2.3 trillion “infrastructure” package. We didn’t hear much about foreign affairs. That’s because he’s put them on the back burner to press forward with his “transformative,” and unprecedentedly expensive, domestic agenda.
The singer's latest song, “Montero (Call Me by Your Name)," is a smash hit.